AQR Capital Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
|
|||||
|
2025
Q1 | $115K | Sell |
|
|||||
|
2024
Q4 | $224K | Buy |
|
|||||
|
2024
Q3 | $152K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $107K | Sell |
|
|||||
|
2023
Q4 | $233K | Sell |
|
|||||
|
2023
Q3 | $211K | Buy |
|
|||||
|
2023
Q2 | $218K | Sell |
|
|||||
|
2023
Q1 | $224K | Sell |
|
|||||
|
2022
Q4 | $316K | Buy |
|
|||||
|
2022
Q3 | $54K | Sell |
|
|||||
|
2022
Q2 | $142K | Buy |
|
|||||
|
2022
Q1 | $141K | Buy |
|
|||||
|
2021
Q4 | $151K | Sell |
|
|||||
|
2021
Q3 | $647K | Buy |
|
|||||
|
2021
Q2 | $832K | Sell |
|
|||||
|
2021
Q1 | $1.07M | Buy |
|
|||||
|
2020
Q4 | $1.01M | Sell |
|
|||||
|
2020
Q3 | $431K | Sell |
|
|||||
|
2020
Q2 | $610K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $131K | Buy |
|